Ten63 Therapeutics: $15.9 Million Raised To Combine Generative AI And Physics-Based Models
Ten63 Therapeutics – a company combining generative AI and physics-based models to develop first- and best-in-class therapeutics – announced the closing of an oversubscribed $15.9 million Series A financing led by new investor Hatteras Venture Partners.
Swain Lenz to Speak at Large Genomic Conference
Sequencing and Genomic Technologies Director, Devjanee (Devi) Swain Lenz will be one of the invited panel speakers at the Festival of Genomics and Biodata conference
Outsmarting Superbugs, One Germ at a Time
It’s an old story: Pathogen sickens humans. Humans create medicine. Pathogen evolves a way around the medicine. Humans are back to square one.
Collaboration Seeks Genetic Clues to Chronic Lung Disease
Idiopathic pulmonary fibrosis (IPF) is a disease that causes scarring on the lungs. Over time, as more scarring occurs, patients experience decreased lung function and difficulty breathing. Once diagnosed, most patients die within five years.
Study Reveals How UV Radiation May Drive Melanoma
Raluca Gordân, PhD, and team investigated how transcription factors may affect the production of genetic mutations, or mutagenesis, by binding to the wrong sites after being exposed to ultraviolet (UV) radiation.
Alumnus Ariel Kantor Cited by Forbes Europe in 30 Under 30 List
Duke alumnus, former member of the Gersbach lab, and Rhodes Scholar Ariel Kantor was selected for Forbes Europe's latest "30 under 30" — an annual listing of top young innovators, entrepreneurs and world changers.
Synthetic Compartments Stop Pathogens from Sharing Antibiotic Resistance Genes
Biomedical engineers at Duke University have demonstrated a new synthetic approach to controlling cellular biochemical processes.
Mouse lemur genomes shed light on climate as a driver of speciation
Sure, lemurs are adorable. With their big eyes, some even look like they belong in a Disney forest. But that is definitely not what drives Anne Yoder’s passion to research these primates.
New Year, New NextSeq
The Sequencing and Genomic Technologies core facility has acquired a new sequencing platform. The llumina NextSeq 1000 produces 100-400 M reads at a variety of read lengths, including 300 bp paired-end reads at a fraction of the price of the NextSeq 500 and MiSeq.